If Maggie O'Neil can't find a bone marrow match among family members, she'll have to turn to an anonymous donor through the ...
Galinpepimut-S therapy showed specific T-Cell immune responses for patients with acute myeloid leukemia in remission ...
Discover how groundbreaking research on unique immune cells and advanced AI tools offers renewed hope for improving cancer ...
News Medical on MSN10d
Immune environment found to influence success of leukemia immunotherapyA research team from Columbia Engineering and the Irving Institute for Cancer Dynamics made a pivotal discovery in the field ...
Dana-Farber Cancer Institute researchers have identified factors that determine whether donor lymphocyte infusion (DLI), a ...
The following is a summary of “Protocol of a decisional intervention for older adults with newly diagnosed acute myeloid ...
Idaho Statesman on MSN11d
‘They’re so strong.’ Leukemia took her mom. Eagle basketball went orange in her honorJunior guard Audrey Baxter lost her mom to acute myeloid leukemia last March. “I don’t know a lot of people that would be ...
The FDA has approved GRAFAPEX™ and fludarabine as a preparative regimen in acute myeloid leukemia or myelodysplastic syndrome ...
Researchers have identified key factors that determine the success of leukemia cell therapies, including DLI, in achieving ...
The phase 3 REGAL trial of galinpepimut-S in acute myeloid leukemia can proceed without modifications, based on findings from ...
Columbia Engineering and Irving Institute researchers unveil a significant finding in cancer immunotherapy, uncovering unique ...
A research team made a pivotal discovery in the field of cancer immunotherapy. The team identified a specific population of immune cells that play a critical role in successful treatment of relapsed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback